Come up with a name for your new list and we'll add to it:
Cerecin raised a round of funding on May 24, 2012. Investors include
Inventages Venture Capital.
Cerecin, fka Accera, is a biopharmaceutical company with a drug for Alzheimer's in late stage clinical testing. Accera's pipeline consists of therapeutic drugs and medical foods for neurodegenerative …